You just read:

Society for Neuroscience 2016 Annual Meeting Nanosymposium Explores Potential of "Sigma-2/PGRMC1 Receptor Function in Disease and Therapeutics"

News provided by

Cognition Therapeutics, Inc. (CogRx)

30 Nov, 2016, 08:32 ET